这项研究通过利用干细胞技术开发出一种通用的小直径血管移植物，为心血管疾病的治疗提供了新的可能性。研究团队成功解决了传统移植物来源有限和免疫排斥的问题，通过生物工程手段实现了移植物的稳定性和功能性。这一成果不仅展示了干细胞在再生医学中的巨大潜力，还为未来的临床应用奠定了基础。如果这种移植物能够在人类临床试验中取得成功，将为心血管疾病患者带来福音，特别是在冠状动脉旁路手术中。

Recently developed major histocompatibility complex (MHC) multimer technologies allow visualization and isolation of antigen-specific T cells. However, functional analysis and in vivo transfer of ...

Detailed price information for Imac Holdings Inc (BACK-Q) from The Globe and Mail including charting and trades.

Through RNA sequencing, they found that BAP1 increased the expression of several MHC-II genes, which are known to play a critical role in the body's immune responses. Next, scientists focused on B ...

Interestingly, the team also discovered that the epithelial cells try and control this inflammation by using a specialized immune-facing molecule called MHC-II. They do so by using MHC-II to ...

Viral protein is made intracellularly and the protein is processed via the endogenous MHC class I pathway. DNA vaccines. DNA vaccines favor a cell-mediated immune response. DNA plasmid vector ...